sevoflurane and remifentanil

PreclinicalSmall molecule

YYeungnam University College of Medicine

sevoflurane and remifentanil is one of 26 small molecule programs targeting Hypotension. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HypotensionActive, not recruiting

HypotensionPreclinical

Active, not recruiting

Competition

Competitive Landscape

136 competitors in Hypotension

#DrugCompanyPhaseTrials

Levophed

GGeneral Hospital of Ningxia Medical University

Phase 3

34 2

Firazyr

Takeda

Phase 3

1 3

Cortef

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

3 4

Midodrine Hydrochloride

Takeda

Phase 3

1 5

Noradrenaline

IInstitute of Liver and Biliary Sciences, India

Phase 3

2 6

L-Carnitine

IIperboreal Pharma Srl

Phase 3

1 7

Marcaine

IInnocoll

Phase 2

2 8

Bronitin Mist

LLongeveron Inc.

Phase 3

2 9

Voluven

RRegional Hospital Holstebro

Phase 3

3 10

Hemospan (MP4OX)

SSangart

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Acute Postoperative Pain1 trial

Propofol Versus Sevoflurane on Acute Postoperative Pain

Completed·YYeungnam University College of Medicine·N/A·NCT04333992·48 enrolled

Laparoscopic Surgery1 trial

Interaction of Sevoflurane Propofol and Remifentanil in Anesthesia for Laparoscopic Surgery

Completed·IInsel Gruppe AG, University Hospital Bern·Phase 4·NCT02457442·172 enrolled

Quality of Recovery1 trial

EEG and ANI Guided Anesthesia and Quality of Recovery

Recruiting·GGangnam Severance Hospital·N/A·NCT05936671·126 enrolled

Hypotension1 trial

Anesthesia Techniques, Neuroprotection and Surgical Field in FESS Under Controlled Hypotension

Recruiting·—·N/A·NCT07181564·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for sevoflurane and remifentanil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — sevoflurane and remifentanil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for sevoflurane and remifentanil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Yeungnam University College of Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: YYeungnam University College of Medicine

sevoflurane and remifentanil

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Acute Postoperative Pain1 trial

Laparoscopic Surgery1 trial

Quality of Recovery1 trial

Hypotension1 trial

References

Drug Info

Quick Facts

Related News